Trials / Completed
CompletedNCT05407818
A Study of JNJ-63733657 in Healthy Chinese Participants
A Phase 1, Open-label, Single Dose Study to Investigate Pharmacokinetics, Safety and Tolerability of JNJ-63733657 in Healthy Chinese Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Janssen Research & Development, LLC · Industry
- Sex
- All
- Age
- 55 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the pharmacokinetics (PK) of JNJ-63733657 following single intravenous (IV) dose administration in healthy Chinese participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JNJ-63733657 | JNJ-63733657 will be administered as an IV infusion. |
Timeline
- Start date
- 2022-06-27
- Primary completion
- 2022-08-02
- Completion
- 2022-11-07
- First posted
- 2022-06-07
- Last updated
- 2025-04-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05407818. Inclusion in this directory is not an endorsement.